Kwality Pharmaceuticals has successfully obtained product approval in South Africa (SAHPRA) for its prominent oncology oral solid dosage (OSD) product, Tamoxifen 20mg Tablet, through a site transfer process.
This approval is a significant achievement in expanding the availability of this critical therapeutic, which plays a vital role in the treatment of hormone receptor-positive breast cancer. It reflects its ongoing commitment to providing high-quality, accessible oncology treatments to patients in key markets. This approval further strengthens its presence in the High Regulated and global oncology market.
Kwality Pharmaceuticals (formerly Kwality Pharmaceuticals) is a pharmaceutical formation company.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1657.70 |
| Dr. Reddys Lab | 1213.25 |
| Cipla | 1227.75 |
| Zydus Lifesciences | 927.65 |
| Lupin | 2305.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: